Clinical Trials

Find a Clinical Trial

2 Clinical Trials

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of ralinepag.

Interventional / Recruiting / NCT03683186

Clinical Trial Details

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World Health Organization (WHO) Group 1 PAH.

Interventional / Recruiting / NCT03626688

Clinical Trial Details

Commonly Searched Clinical Trials

View All Clinical Trials
Breast Cancer
CAR T-Cell Therapy
Crohn's Disease
Diabetes
Leukemia
Neuroblastoma
Neurosciences
Ovarian Cancer
Prostate Cancer

Please note that acceptance into any study is dependent on full clinical evaluation as well as details of study status, both of which can only be fully evaluated at the time of a formal visit and screening.